Characteristic Distinctions Between Pre-/Post-COVID-19 Teledermatology Adoptees: A Cross-Sectional United States-based Analysis and the Implications for Dermatologic Healthcare Equity
Journal of Drugs in Dermatology · 2023
DOI: 10.36849/jdd.7169 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Drugs in Dermatology, 2023. Verfasst von Justin Marson und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatology, COVID-19, Skin Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Marson, J., Ahmad, M., Litchman, G., Zakria, D., Perkins, S., & Rigel, D. (2023). Characteristic Distinctions Between Pre-/Post-COVID-19 Teledermatology Adoptees: A Cross-Sectional United States-based Analysis and the Implications for Dermatologic Healthcare Equity. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7169
Vancouver
Marson J, Ahmad M, Litchman G, Zakria D, Perkins S, Rigel D. Characteristic Distinctions Between Pre-/Post-COVID-19 Teledermatology Adoptees: A Cross-Sectional United States-based Analysis and the Implications for Dermatologic Healthcare Equity. Journal of Drugs in Dermatology. 2023. doi:10.36849/jdd.7169
BibTeX
@article{Marson2023,
author = {Marson, Justin and Ahmad, Maham and Litchman, Graham and Zakria, Danny and Perkins, Sara and Rigel, Darrell},
title = {Characteristic Distinctions Between Pre-/Post-COVID-19 Teledermatology Adoptees: A Cross-Sectional United States-based Analysis and the Implications for Dermatologic Healthcare Equity},
journal = {Journal of Drugs in Dermatology},
year = {2023},
doi = {10.36849/jdd.7169}
}
EUVIMED